Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-14

Clinical Trial Update: A Study to Evaluate the Safety and the Efficacy of EscharEx (EX-02 Formulation) in Debridement of Venous Leg Ulcers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of EscharEx in debridement of venous leg ulcers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EscharEx (EX-02 Formulation) (EscharEx EX-02)

Snippet

Sponsor: MediWound Ltd | Conditions: Venous Leg Ulcer | Phase 2 | Status: COMPLETED